<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.5 --><!--Automatically converted from version 2.3 to 2.4-->

<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>

   <PublisherInfo>

      <PublisherName>Springer-Verlag</PublisherName>

      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>

   </PublisherInfo>

   <Journal>

      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">

         <JournalID>105</JournalID>

         <JournalPrintISSN>0017-8470</JournalPrintISSN>

         <JournalSPIN/>

         <JournalTitle>Der Hautarzt</JournalTitle>

         <JournalSubTitle>Zeitschrift für Dermatologie, Allergologie, Venerologie und verwandte Gebiete</JournalSubTitle>

         <JournalAbbreviatedTitle>Hautarzt</JournalAbbreviatedTitle>
         <JournalSubjectGroup>
            <JournalSubject Type="Primary">Legacy</JournalSubject>
         </JournalSubjectGroup>

      </JournalInfo>

      <Volume>

         <VolumeInfo VolumeType="Regular">
            <VolumeIDStart>46</VolumeIDStart>
            <VolumeIDEnd>46</VolumeIDEnd>
            <VolumeIssueCount/>
         </VolumeInfo>

         <Issue IssueType="Regular">

            <IssueInfo TocLevels="0">

               <IssueIDStart>11</IssueIDStart>

               <IssueIDEnd>11</IssueIDEnd>

               <IssueHistory>

                  <PrintDate>

                     <Year>1995</Year>

                     <Month>11</Month>

                     <Day>15</Day>

                  </PrintDate>

                  <CoverDate>

                     <Year>1995</Year>

                     <Month>11</Month>

                  </CoverDate>

               </IssueHistory>

               <IssueCopyright>

                  <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                  <CopyrightYear>1995</CopyrightYear>

               </IssueCopyright>

            </IssueInfo>

            <Article ID="Art1">

               <ArticleInfo Language="De" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" ContainsESM="No" TocLevels="0">

                  <ArticleID>50460755.105</ArticleID>

                  <ArticleDOI>10.1007/s001050050335</ArticleDOI>

                  <ArticleTitle Language="De">Transgene Mäuse als Modelle für Hautkrankheiten</ArticleTitle>

                  <ArticleSubTitle Language="De"/>

                  <ArticleCategory>ÜBERSICHT</ArticleCategory>

                  <ArticleFirstPage>755</ArticleFirstPage>

                  <ArticleLastPage>761</ArticleLastPage>

                  <ArticleCopyright>

                     <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                     <CopyrightYear>1995</CopyrightYear>

                  </ArticleCopyright>
                  <ArticleGrants>
                     <MetadataGrant Grant="OpenAccess"/>
                     <AbstractGrant Grant="OpenAccess"/>
                     <BodyPDFGrant Grant="Restricted"/>
                     <BodyHTMLGrant Grant="Restricted"/>
                     <BibliographyGrant Grant="Restricted"/>
                     <ESMGrant Grant="Restricted"/>
                  </ArticleGrants>

               </ArticleInfo>

               <ArticleHeader>

                  <AuthorGroup>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Klaus</GivenName>

                           <FamilyName>Sellheyer</FamilyName>

                        </AuthorName>

                     </Author>

                     <Affiliation ID="A1">

                        <OrgName>Department of Cell Biology (Chairman: Prof. Dr. B.W. O'Malley) und Department of Dermatology (Chairman: Prof. Dr. J.E. Wolf, Jr.) am Baylor College of Medicine, Houston, Texas, USA und Hautklinik (Direktor: Prof. Dr. E. Haneke) am Klinikum, Wuppertal</OrgName>

                        <OrgAddress>

                           <Street/>

                           <Postbox/>

                           <Postcode/>

                           <City/>

                           <State/>

                           <Country>US</Country>

                        </OrgAddress>

                     </Affiliation>

                  </AuthorGroup>

                  <Abstract ID="Abs1" Language="De">

                     <Heading>Zusammenfassung</Heading>

                     <Para/>

                     <Para>

                        <Emphasis Type="Italic">Für die Mehrheit auch der häufigen Dermatosen fehlen geeignete, in der Natur vorkommende Tiermodelle. Die in den 80er Jahren begründete transgene Technologie schließt diese Lücke. Sie war zunächst Instrument in der Hand reiner Grundlagenwissenschaftler, hat aber in den letzten fünf Jahren auch Einzug in die klinisch orientierte spezifisch dermatologische Grundlagenforschung gehalten. Mit ihr wurde es möglich, HIV-assoziierte Erkrankungen wie auch Genodermatosen am murinen Modell zu imitieren und Einblicke in deren Pathogenese zu gewinnen. Durch gezielte epidermal lokalisierte Überexpression von Wachstumsfaktoren und Zytokinen wies die Haut transgener Mäuse Ähnlichkeiten mit psoriatischer Epidermis auf. Gleichzeitig können solcherart erzeugte Mäuse zu Untersuchungen des Wundheilungsprozesses herangezogen werden. Die transgene Technologie ermöglicht fernerhin die Induktion kutaner Tumoren. Das Vorliegen von Tiermodellen humaner Dermatosen erlaubt darüber hinaus die gezielte Erforschung experimenteller Therapieformen, wie z.B. der somatischen Gentherapie.</Emphasis>

                     </Para>

                  </Abstract>

                  <Abstract ID="Abs2" Language="En">

                     <Heading>Summary</Heading>

                     <Para/>

                     <Para>Naturally occurring animal models are not available even for most common skin diseases. Transgenic technology developed during the 1980s is closing this gap. It was initially used as a tool by scientists in basic research, but during the last 5 years it has increasingly been applied by clinically oriented basic researchers in dermatology. This technique, has made it possible to imitate HIV-associated diseases and genodermatoses in the murine model and to elucidate their pathogenesis. Owing to specifically induced epidermally localized overexpression of growth factors and cytokines, the skin of transgenic mice exhibited similarities to those of the psoriatic epidermis. Such animals are also useful for studying wound healing. Furthermore, transgenic technology enables us to induce cutaneous tumors selectively. The availability of animal models for human skin diseases is also of value in elucidating experimental therapeutic approaches, e.g. the somatic gene therapy.</Para>

                  </Abstract>

                  <KeywordGroup Language="De">

                     <Keyword>Schlüsselwörter Transgene Mäuse</Keyword>

                     <Keyword>Kaposi-Sarkom</Keyword>

                     <Keyword>Genodermatosen</Keyword>

                     <Keyword>Wundheilung</Keyword>

                     <Keyword>Gentherapie</Keyword>

                  </KeywordGroup>

                  <KeywordGroup Language="En">

                     <Keyword>Key words Transgenic mice</Keyword>

                     <Keyword>Kaposi's sarcoma</Keyword>

                     <Keyword>Genodermatoses</Keyword>

                     <Keyword>Wound healing</Keyword>

                     <Keyword>Gene therapy</Keyword>

                  </KeywordGroup>

                  <ArticleNote Type="Misc">

                     <SimplePara>Eingegangen am 14. November 1994 Angenommen am 22. Februar 1995</SimplePara>

                  </ArticleNote>

               </ArticleHeader>

               <NoBody/>

            </Article>

         </Issue>

      </Volume>

   </Journal>

</Publisher>